NLS Agreement

Navamedic has partnered with Alex Therapeutics to aid in Parkinson’s treatment management.

Rokote Laboratories Finland has selected 3PBIOVIAN as their CDMO partner for GMP manufacturing of adenovirus type 5 (Ad5) vector-based candidate expressing a modified spike protein of severe acute respiratory coronavirus 2. 3PBIOVIAN will provide Rokote Laboratories with Drug Substance and Drug Product to bring the intranasal FINCoVac 2.1 vaccine into Phase I clinical studies. The […]

The Swedish biotech company has entered into a research collaboration agreement with Eli Lilly and Company to apply its AbiProt technology to generate antibodies against a well-validated target protein. This partnership aims to accelerate research and development of innovative treatments and, if successful, will generate milestone payments and royalty income, states the company. Under the […]

Xbrane Biopharma will regain full rights to BIIB801 following a decision by Biogen to terminate the commercialization and license agreement between the companies. All rights to the product will be reverted to Xbrane. An out-licensing process to identify a new partner has been initiated. BIIB801 is a preclinical monoclonal antibody fragment that is a proposed […]

SmartCella has announced a new share issue to accelerate growth and support commercialization of the Extroducer and the company’s cell and mRNA operations. The share issue was supported by existing large institutional investors such as Fjärde AP-fonden, AMF Pension and SEB-Stiftelsen, as well as a new long-term strategic investor, AstraZeneca (committing to approximately half of […]

SciBase Holding continues to expand in California with a collaboration agreement with Unified Health. Unified Health has nine clinics in Southern California. “At Unified Health, we believe in providing our patients with exceptional medical care and access to the most advance medical technology. Our experienced team of providers are committed to delivering the highest quality […]